Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(6)
MIXED(3)
BIOLOGICAL(3)
Fludarabine + Cyclophosphamide
2 trials
phase_1
hryz-biotech-co
Gentulizumab
1 trial
phase_1
changchun-genescience-pharmaceutical-co-ltd
FDA018-ADC
1 trial
phase_1
shanghai-fudanzhangjiang-biopharmaceutical-co-ltd
Toripalimab
1 trial
phase_1
bgi-china
HRYZ-T101 Injection
1 trial
phase_1
hryz-biotech-co
Leuprorelin Acetate Microspheres for Injection
1 trial
phase_3
changchun-genescience-pharmaceutical-co-ltd
Neo-T
1 trial
phase_1
bgi-china
LB4330
1 trial
phase_1
l-l-bio-co-ltd-ningbo-china

+3 more interventions

11 unique interventions3 categories

Analytics

Trial Phases

Phase 16
Phase 31

Trial Status

Recruiting1
Terminated2
Other4

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT06449027Phase 3Active Not Recruiting
Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.
Breast Cancer Subjects
PrincipalinvestigatorStart date: 2024-08-21
NCT05952947Phase 1Recruiting
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
Anal CancerCarcinoma of PenisCarcinoma of Vagina+3 more
PrincipalinvestigatorStart date: 2023-11-01
NCT05787535Phase 1Unknown
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
Anal CarcinomaCarcinoma of PenisCarcinoma of Vulva+4 more
PrincipalinvestigatorStart date: 2023-03-21
NCT05798533Phase 1Unknown
Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
Solid Tumor
PrincipalinvestigatorStart date: 2023-01-10
NCT05707676Phase 1Terminated
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（MEETCD8-001）
Solid Tumor
PrincipalinvestigatorStart date: 2022-11-30
NCT05174637Phase 1Active Not Recruiting
A Study of FDA018-ADC in Patients With Advanced Solid Tumors
Advanced/ Metastatic Solid Tumors
PrincipalinvestigatorStart date: 2021-10-22
NCT05221385Phase 1Terminated
Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma
Non-Hodgkin LymphomaSolid Tumor
PrincipalinvestigatorStart date: 2021-04-12

Research Network

Collaboration Network

6 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xiaohua Wu, Doctor

Fudan University

Similar
3 trials

Shared therapeutic areas:

Cancer of the Uterine CervixAnal CancerCarcinoma of Penis+3 more

Worked with same sponsors:

Fudan UniversityHRYZ Biotech Co.+1 more
Collaborated on 1 trial
Similarity Score64%

Zhimin Shao, Doctor

Fudan University

Related
1 trials

Shared therapeutic areas:

Breast Cancer Subjects

Worked with same sponsors:

Changchun GeneScience Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Xianjun Yu, Doctor

Fudan University

Related
3 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

L & L Bio Co., Ltd., Ningbo, China
Collaborated on 1 trial
Similarity Score14%

Qing Xu, Doctor

Shanghai 10th People's Hospital

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

BGI, ChinaFudan University+1 more
Collaborated on 1 trial
Similarity Score14%

Yong Chen, Doctor

Fudan University

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

BGI, ChinaFudan University+1 more
Collaborated on 1 trial
Similarity Score14%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Cancer of the Uterine CervixAnal CancerCancer of Oropharnyx
Similarity Score7%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Cancer of OropharnyxSquamous Cell Carcinoma of Head and NeckSolid Tumor
Similarity Score7%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine CervixSolid Tumor
Similarity Score5%

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
17 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckSolid Tumor
Similarity Score5%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinSolid Tumor
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT06449027Phase 3PrincipalInvestigator

Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.

Breast Cancer Subjects
Active Not Recruiting
NCT05952947Phase 1PrincipalInvestigator

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

Anal CancerCarcinoma of PenisCarcinoma of Vagina+3 more
Recruiting
NCT05787535Phase 1PrincipalInvestigator

HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor

Anal CarcinomaCarcinoma of PenisCarcinoma of Vulva+4 more
Unknown
NCT05798533Phase 1PrincipalInvestigator

Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)

Solid Tumor
Unknown
NCT05707676Phase 1PrincipalInvestigator

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（MEETCD8-001）

Solid Tumor
Terminated
NCT05174637Phase 1PrincipalInvestigator

A Study of FDA018-ADC in Patients With Advanced Solid Tumors

Advanced/ Metastatic Solid Tumors
Active Not Recruiting
NCT05221385Phase 1PrincipalInvestigator

Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma

Non-Hodgkin LymphomaSolid Tumor
Terminated

All 7 trials loaded